INITIAL STEP OF ASSESSING THE RESULT OF FOLAT TREATMENT IN RECURRENT PREGNANCY LOSS PATIENTS CARRYING THE MTHFR MUTATED GENE

Lê Thị Anh Đào1,, Lưu Thị Anh2
1 Hanoi Medical University
2 Hanoi Obstetrics and Pediatrics Hospital

Main Article Content

Abstract

Recurrent pregnancy loss (RPL) and gene MTHFR polymorphism have been found to be strongly associated in Asian people. Folate treatment is believed to reduce blood homocysteine ​​levels and improve pregnancy outcomes. Objective: the study aims to evaluate the results of folate treatment in patients carrying the MTHFR C677T polymorphism at Hanoi Obstetrics and Gynecology Hospital. A cross-sectional study of 30 patients with a history of RPL and MTHFR mutation was treated with 5 mg folate/day during 3 months. Results 100% of patients carried the CT heterozygous MTHFR gene. The average concentration of homocysteine ​​before and after treatment was 10.3±3.47; 6.8±2.48 µmol/l respectively, (p=0,000). Conclusion: Folate treatment during 3 months reduces homocysteine ​​levels in the blood.

Article Details

References

1. Hui Chen, Xiaorong Yang, Ming Lu, Methylenetetrahydrofolate reductase gene polymorphisms and recurrent pregnancy loss in China: a systematic review and meta-analysis. Archives of Gynecology and Obstetrics, 2016. 293(2): p.283-290.
2. Lê Thị Anh Đào, Nghiên cứu hội chứng kháng phospholipid ở thai phụ có tiền sử sẩy thai liên tiếp đến 12 tuần. 2016, Đại học Y Hà Nội.
3. Serapinas D; Boreikaite E; Bartkeviciute A; et al, The importance ò folate, vitamins B6 and b12 for the lowering of homocysteine concentrations for patients with recurrent.
4. Ganji, V. and M.R. Kafai, Demographic, life: and health characteristics and serum B vitamin status are determinants of plasma total homocysteine concentration in the post-folic acid fortification period, 1999-2004. J Nutr, 2009. 139(2); p.345-52.